Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000172310 | SCV000051255 | uncertain significance | not provided | 2013-06-24 | criteria provided, single submitter | research | |
Laboratory for Molecular Medicine, |
RCV000152304 | SCV000201173 | uncertain significance | not specified | 2013-09-19 | criteria provided, single submitter | clinical testing | Variant classified as Uncertain Significance - Favor Benign. The Gly15724Arg var iant in TTN has not been reported in individuals with cardiomyopathy but has bee n identified in 1/8178 European American chromosomes by the NHLBI Exome Sequenci ng Project (http://evs.gs.washington.edu/EVS/; dbSNP rs377512675). Glycine (Gly) at position 15724 is not conserved across mammals and suggests that a change at this position may be tolerated despite high adjacent conservation. Additionally , computational analyses (biochemical amino acid properties, AlignGVGD, PolyPhen 2, and SIFT) do not provide strong support for or against an impact to the norma l function of the protein. In summary, additional information is needed to fully assess the clinical significance of the Gly15724Arg variant. |
Gene |
RCV000152304 | SCV000725620 | likely benign | not specified | 2017-12-05 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |